Guest guest Posted December 26, 2007 Report Share Posted December 26, 2007 http://hcrenewal.blogspot.com/2007/12/data-about-ezetimibe-adverse-effects.html Here we go again. Last week, an article by Alex Berenson in the New York Times reported that Merck and Schering-Plough conducted trials of ezetimibe (Zetia, by Schering-Plough, and a component of Vytorin, by Merck) "that raise questions about its risks to the liver," but never publicly reported their results. http://www.grisoft.com Anti-Virus Scanned this message Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.